A 12 weeks study to evaluate effect of revamilst in addition tomethotrexate in rheumatiod arthritis patients. A 12 weeks study to evaluate effect of revamilst in addition tomethotrexate in rheumatiod arthritis ...
A Phase IIb, 12 week Randomized, Double-Blind, Parallel Group, Placebo-Controlled study to evaluate Efficacy, Safety and Tolerability of 2, 4 and 6 mg of Revamilast in patients with Active Rheumatoid Arthritis who have had an inadequate response to Methotrexate. A Phase IIb, 12 week Randomized, Double-Blind, Parallel Group, Placebo-Controlled study to evaluate ...